Search research articles
Contact Us
Filters
Showing results (1131-1140 of 1,198) with videos related to
Page
of 120
Sort By:
Viruses
|
July 30, 2025
Integrated Analysis of the 2022 SARS-CoV-2 Omicron Lineage Replacement Dynamics in Connecticut, US
Nicholas F G Chen, Kien Pham, Chrispin Chaguza, et al.
European Urology Oncology
|
May 29, 2021
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma
Michael A Gorin, Hiten D Patel, Steven P Rowe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 27, 2013
EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladder
Riley E Alexander, Rodolfo Montironi, Antonio Lopez-Beltran, et al.
Current Biology : CB
|
February 28, 2017
Coordination by Cdc42 of Actin, Contractility, and Adhesion for Melanoblast Movement in Mouse Skin
Emma F Woodham, Nikki R Paul, Benjamin Tyrrell, et al.
Clinical Lung Cancer
|
October 20, 2018
Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location
Caitlin A Schonewolf, Marina Heskel, Abigail Doucette, et al.
Nature Communications
|
November 5, 2022
Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer
Jeffrey S Damrauer, Wolfgang Beckabir, Jeff Klomp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2017
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)
Martin J Edelman, Xiaofei Wang, Lydia Hodgson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 6, 2014
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)
William M Sikov, Donald A Berry, Charles M Perou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 20, 2015
A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma
Sumanta Pal, Arun Azad, Shailender Bhatia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2018
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Christos E Kyriakopoulos, Yu-Hui Chen, Michael A Carducci, et al.
Page
of 120
Search research articles
Search
Showing results (1131-1140 of 1,198) with videos related to
Sort By:
Page
of 120
Viruses
|
July 30, 2025
Integrated Analysis of the 2022 SARS-CoV-2 Omicron Lineage Replacement Dynamics in Connecticut, US
Nicholas F G Chen, Kien Pham, Chrispin Chaguza, et al.
European Urology Oncology
|
May 29, 2021
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma
Michael A Gorin, Hiten D Patel, Steven P Rowe, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 27, 2013
EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladder
Riley E Alexander, Rodolfo Montironi, Antonio Lopez-Beltran, et al.
Current Biology : CB
|
February 28, 2017
Coordination by Cdc42 of Actin, Contractility, and Adhesion for Melanoblast Movement in Mouse Skin
Emma F Woodham, Nikki R Paul, Benjamin Tyrrell, et al.
Clinical Lung Cancer
|
October 20, 2018
Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location
Caitlin A Schonewolf, Marina Heskel, Abigail Doucette, et al.
Nature Communications
|
November 5, 2022
Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer
Jeffrey S Damrauer, Wolfgang Beckabir, Jeff Klomp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 11, 2017
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)
Martin J Edelman, Xiaofei Wang, Lydia Hodgson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 6, 2014
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance)
William M Sikov, Donald A Berry, Charles M Perou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 20, 2015
A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma
Sumanta Pal, Arun Azad, Shailender Bhatia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2018
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Christos E Kyriakopoulos, Yu-Hui Chen, Michael A Carducci, et al.
Page
of 120